The North America breast reconstruction market size is anticipated to reach USD 486.6 million by 2025 at a 4.5% CAGR during the forecast period, according to a new report by Grand View Research, Inc. This growth can be attributed to increased awareness about physical appearance, particularly among women.
Breast reconstruction is considered to be one of the top 5 cosmetic surgical procedures in U.S. since 2006. According to estimates, there has been a 39.0% increase in this procedure since 2000 and a 3.0% rise since 2015. Thus, with rising number of reconstruction procedures being performed, demand for associated products such as implants and tissue expanders has also increased.
According to the Agency for Healthcare Research and Quality, the number of women undergoing mastectomy procedures has increased by 36.0% during the period of 2005to 2013. Increasing prevalence of breast cancer, high mortality rate associated with it, and growing number of mastectomies being performed as a result are some of the factors anticipated to drive demand for implants and tissue expanders.
Furthermore, availability of advanced technologies in this field has supported market growth. For instance, single-stage breast reconstruction has evolved as an innovative technique that combines tissue expanders and implants into a single product.
Further key findings from the study suggest:
Breast reconstruction is considered to be one of the top 5 cosmetic surgical procedures in U.S. since 2006. According to estimates, there has been a 39.0% increase in this procedure since 2000 and a 3.0% rise since 2015. Thus, with rising number of reconstruction procedures being performed, demand for associated products such as implants and tissue expanders has also increased.
According to the Agency for Healthcare Research and Quality, the number of women undergoing mastectomy procedures has increased by 36.0% during the period of 2005to 2013. Increasing prevalence of breast cancer, high mortality rate associated with it, and growing number of mastectomies being performed as a result are some of the factors anticipated to drive demand for implants and tissue expanders.
Furthermore, availability of advanced technologies in this field has supported market growth. For instance, single-stage breast reconstruction has evolved as an innovative technique that combines tissue expanders and implants into a single product.
Further key findings from the study suggest:
- By product, tissue expanders held the largest market share in 2017 and the segment is anticipated to exhibit significant growth over the forecast period due to their high application in mastectomy and lumpectomy surgeries
- Breast implants generated significant revenue in 2017 owing to significant concern among people to improve or alter their physical appearances
- Round shaped implants dominated the market in 2017. These result in soft, round, and accurately proportioned breasts and eliminate any risk arising from implant rotation
- Round shaped expanders are also expected to witness lucrative growth over the forecast period due to their ability to minimize visibility of implant ripples through the skin
- Anatomical shaped products are expected to show significant CAGR over the forecast period as they present lower risk of capsular contracture as compared to smooth implants and also give a natural-looking appearance
- U.S. dominated the regional market in 2017 due to increase in number of breast reconstruction surgeries in the country
- Canada is anticipated to show significant growth over the forecast period due to rising prevalence of breast cancer among the Canadian population
- Some of the major manufacturers are Mentor Worldwide LLC; Sientra, Inc.; IDEAL IMPLANT INCORPORATED; and Allergan.
